Transmedics Group Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Transmedics Group Inc 公司

TransMedics Group, Inc. 是一家醫療技術公司，致力於爲患有晚期肺、心和肝功能衰竭的患者提供器官移植療法轉型。該公司專門從事便攜式體外溫灌注和移植捐獻器官評估。其器官護理系統 (OCS) 是一種便攜式器官灌注、優化和監測系統，利用其定製技術在人體外複製捐獻器官的近生理條件。該公司還開發了國家 OCS 計劃 (NOP)，這是一個交鑰匙解決方案，提供外包器官檢索、OCS 器官管理和物流服務，以在美國開展移植計劃。其物流服務包括航空運輸、地面運輸和其他協調活動。其 NOP 提供經過培訓的器官採購外科醫生、臨牀專家和移植協調員，利用其 OCS 技術提供端到端臨牀解決方案。

公司簡介

公司代碼TMDX

公司名稱Transmedics Group Inc

上市日期May 02, 2019

成立日期2018

CEODr. Waleed H. Hassanein, M.D.

員工數量728

證券類型Ordinary Share

年結日May 02

公司地址200 Minuteman Road

城市ANDOVER

上市交易所NASDAQ Global Market Consolidated

國家United States of America

郵編01810

電話19785520900

網址https://www.transmedics.com/

公司代碼TMDX

上市日期May 02, 2019

成立日期2018

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Waleed H. Hassanein, M.D.

President, Chief Executive Officer, Director

481.61K

-8.98%

Mr. James R. Tobin

Independent Chairman of the Board

175.07K

-21.19%

Dr. David Weill, M.D.

Independent Director

10.73K

--

Mr. Nicholas (Nick) Corcoran

Senior Vice President - Supply Chain and Operations

7.04K

-44.49%

Ms. Merilee Raines, CPA

Independent Director

1.93K

--

Ms. Stephanie Lovell

Independent Director

1.93K

--

Mr. Thomas James Gunderson

Independent Director

1.93K

--

Mr. Anil Ranganath

Senior Vice President, General Counsel, Corporate Secretary

1.87K

-87.03%

Mr. Gerardo Hernandez

Chief Financial Officer, Treasurer

331.00

-97.93%

Mr. Edwin M. Kania, Jr.

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Waleed H. Hassanein, M.D.

President, Chief Executive Officer, Director

481.61K

-8.98%

Mr. James R. Tobin

Independent Chairman of the Board

175.07K

-21.19%

Dr. David Weill, M.D.

Independent Director

10.73K

--

Mr. Nicholas (Nick) Corcoran

Senior Vice President - Supply Chain and Operations

7.04K

-44.49%

Ms. Merilee Raines, CPA

Independent Director

1.93K

--

Ms. Stephanie Lovell

Independent Director

1.93K

--

收入明細

單位: USD更新時間: 4月6日週日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

OCS Liver net revenue

309.62M

70.83%

OCS Heart net revenue

109.86M

25.13%

OCS Lung net revenue

17.68M

4.04%

地區USD

名稱

營收

佔比

United States

421.88M

96.50%

All other countries

15.28M

3.50%

業務

地區

業務USD

名稱

營收

佔比

OCS Liver net revenue

309.62M

70.83%

OCS Heart net revenue

109.86M

25.13%

OCS Lung net revenue

17.68M

4.04%

股東統計

更新時間: 2月23日週日

持股股東

股東類型

持股股東

股東統計

佔比

BlackRock Institutional Trust Company, N.A.

14.45%

Fidelity Management & Research Company LLC

11.68%

The Vanguard Group, Inc.

10.73%

State Street Global Advisors (US)

4.02%

Macquarie Investment Management

2.93%

Other

56.19%

持股股東

股東統計

佔比

BlackRock Institutional Trust Company, N.A.

14.45%

Fidelity Management & Research Company LLC

11.68%

The Vanguard Group, Inc.

10.73%

State Street Global Advisors (US)

4.02%

Macquarie Investment Management

2.93%

Other

56.19%

股東類型

股東統計

佔比

Investment Advisor

60.18%

Investment Advisor/Hedge Fund

38.06%

Hedge Fund

7.96%

Research Firm

3.62%

Individual Investor

2.99%

Bank and Trust

2.79%

Pension Fund

1.52%

Sovereign Wealth Fund

1.08%

Family Office

0.09%

機構持股

更新時間: 3月5日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

722

40.40M

120.00%

-704.37K

2024Q4

728

40.09M

119.11%

-642.74K

2024Q3

673

39.30M

117.10%

+1.37M

2024Q2

615

36.53M

110.85%

-3.27M

2024Q1

544

37.44M

113.97%

-4.28M

2023Q4

512

38.18M

116.94%

-3.46M

2023Q3

482

38.42M

117.77%

-240.92K

2023Q2

462

35.43M

108.88%

-81.81K

2023Q1

431

32.52M

99.99%

-2.56M

2022Q4

396

31.20M

98.07%

-3.79M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

4.89M

14.52%

+7.50K

+0.15%

Dec 31, 2024

Fidelity Management & Research Company LLC

3.95M

11.74%

+1.99M

+101.32%

Dec 31, 2024

The Vanguard Group, Inc.

3.63M

10.78%

+40.48K

+1.13%

Dec 31, 2024

State Street Global Advisors (US)

1.36M

4.04%

+88.13K

+6.92%

Dec 31, 2024

Macquarie Investment Management

992.50K

2.95%

+96.39K

+10.76%

Dec 31, 2024

UBS Asset Management Switzerland AG

973.96K

2.89%

+45.00K

+4.84%

Feb 28, 2025

Braidwell LP

922.10K

2.74%

+922.10K

--

Dec 31, 2024

UBS Asset Management (Switzerland)

866.16K

2.57%

+839.95K

+3.21K%

Dec 31, 2024

Fidelity International

855.36K

2.54%

+259.51K

+43.55%

Dec 31, 2024

Mackenzie Investments

828.15K

2.46%

+349.40K

+72.98%

Dec 31, 2024

持股ETF

更新時間: 4月6日週日

機構名稱

佔比

Clough Select Equity ETF

3.03%

Clough Hedged Equity ETF

2.66%

SPDR S&P Health Care Equipment ETF

1.53%

Invesco S&P SmallCap Health Care ETF

1.53%

First Trust Nasdaq Lux Digi Health Solutions ETF

1.02%

Invesco S&P SmallCap 600 Pure Growth ETF

0.85%

BNY Mellon Innovators ETF

0.62%

Fidelity Sustainable US Equity ETF

0.57%

WisdomTree US SmallCap Quality Growth Fund

0.43%

SPDR S&P 600 Small Cap Growth ETF

0.33%

Clough Select Equity ETF

佔比3.03%

Clough Hedged Equity ETF

佔比2.66%

SPDR S&P Health Care Equipment ETF

佔比1.53%

Invesco S&P SmallCap Health Care ETF

佔比1.53%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比1.02%

Invesco S&P SmallCap 600 Pure Growth ETF

佔比0.85%

BNY Mellon Innovators ETF

佔比0.62%

Fidelity Sustainable US Equity ETF

佔比0.57%

WisdomTree US SmallCap Quality Growth Fund

佔比0.43%

SPDR S&P 600 Small Cap Growth ETF

佔比0.33%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Transmedics Group Inc

92.430USD

Transmedics Group Inc

92.430

概覽

公司